Patents Assigned to SL VAXIGEN, INC.
  • NOVEL VACCINE ADJUVANT
    Publication number: 20240016925
    Abstract: There is provided a novel vaccine adjuvant, and more specifically, a vaccine adjuvant for stimulating a T lymphocyte-specific immune response, which includes an IL-12 protein and an IL-21 protein as active ingredients, or includes the polynucleotide encoding an IL-12 protein and the polynucleotide encoding an IL-21 protein as active ingredients.
    Type: Application
    Filed: August 4, 2023
    Publication date: January 18, 2024
    Applicant: SL VAXIGEN, INC.
    Inventors: Yong Bok SEO, Youngwoo CHOI, Sang Hee SIM
  • Vaccine adjuvant
    Patent number: 11844834
    Abstract: There is provided a novel vaccine adjuvant, and more specifically, a vaccine adjuvant for stimulating a T lymphocyte-specific immune response, which includes an IL-12 protein and an IL-21 protein as active ingredients, or includes the polynucleotide encoding an IL-12 protein and the polynucleotide encoding an IL-21 protein as active ingredients.
    Type: Grant
    Filed: January 30, 2019
    Date of Patent: December 19, 2023
    Assignee: SL VAXIGEN, INC.
    Inventors: Yong Bok Seo, Youngwoo Choi, Sang Hee Sim
  • A NOVEL VACCINE ADJUVANT
    Publication number: 20200360514
    Abstract: There is provided a novel vaccine adjuvant, and more specifically, a vaccine adjuvant for stimulating a T lymphocyte-specific immune response, which includes an IL-12 protein and an IL-21 protein as active ingredients, or includes the polynucleotide encoding an IL-12 protein and the polynucleotide encoding an IL-21 protein as active ingredients.
    Type: Application
    Filed: January 30, 2019
    Publication date: November 19, 2020
    Applicant: SL VAXIGEN, INC.
    Inventors: Yong Bok SEO, Youngwoo CHOI, Sang Hee SIM